Alexander Lee, MD
Gastroenterology · Dallas, TXNPI 1386805018
Payments from drug & device makers
Across 75 payments — averaging $14.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$316
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$154
- Takeda Pharmaceuticals U.S.A., Inc.$135
- AstraZeneca$68
- Redhill Biopharma Inc.$67
- Ironwood Pharmaceuticals, Inc$49
- plus $265 from 12 others
What the payments were for
- Food & beverage$98093%
- Education$757%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $316 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 20 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $135 |
| AstraZeneca | 1 | $68 |
| Redhill Biopharma Inc. | 4 | $67 |
| Ironwood Pharmaceuticals, Inc | 2 | $49 |
| Merck | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Sanofi | 1 | $29 |
| Johnson & Johnson | 2 | $28 |
| Bristol Myers Squibb | 2 | $25 |
| Intercept Pharmaceuticals, Inc. | 1 | $25 |
| Braintree Laboratories, Inc. | 1 | $23 |
| Boston Scientific | 1 | $18 |
| Davol Inc. | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Endogastric Solutions, Inc | 1 | $13 |
| Gastrogpo, LLC | 4 | $0 |
How this compares
$1,055 in reported general payments places this provider in the 25th percentile of 1,350 gastroenterology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Dallas
- John FordtranDallas$9.9M
- Parvez MantryDallas$6.4M
- Michael BrownDallas$5.5M
- Jacqueline O LearyDallas$1.4M
- Themistocles DassopoulosDallas$1.1M
- Moheb BoktorDallas$1M
- Lisa VanwagnerDallas$486K
- Rodney InfanteDallas$442K
- Eric LawitzSan Antonio$59.5M
- George DuvallTyler$17.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.